Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Kepler Trust Intelligence
05 November 2025
FCSS’s exceptional year has captured all of China’s recovery and more.
Related articles
Investment trusts: how to profit from the world’s most dynamic private companies
Why the fire horse may herald the year of the China investor
The year of the fire horse: can Chinese equities continue their stellar gains?
Related videos
Monthly roundup: Net zero's future, growth capital opportunities and has SMT breached its rules?
Future in focus: what are the biggest risks you see ahead in 2026?
Future in focus: if the tech bubble were to burst, how would it affect your investment trust?
Future in focus: what opportunities do you see ahead in 2026 and beyond?
Related industry news
Morning briefing: Biogen snaps up Apellis in boost BIOG and RTW; Baillie Gifford China Growth bounces back(...)
Biotech Growth (BIOG) and RTW Biotech Opportunities (RTW) have both benefited from Biogen’s announcement of a $5.6bn cash acquisition of Apellis Pharm...
JPMorgan China posts 29% annual return but has more to do in recovering from 2021-22 crash
JPMorgan China Growth & Income (JCGI) chair Alexandra Mackesy has welcomed a narrowing in the investment trust’s underperformance after what she said ...
How the make-or-break Budget could affect trusts
Investment companies are eyeing up the potential impact of what is expected to be a tough Budget from chancellor Rachel Reeve on 26 November.
Trust Spot: Gold bulls and bond bears do battle in dog days of August
Our review of last month’s big risers and fallers shows how concerns about President Trump’s threat to the independence of the Federal Reserve exacerb...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.